The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression
Open accessThe DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: These guidelines are based on a first edition that was published in 2002, and have been edited and updated with the available scientific evidence until September 2009. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute bipolar depression in adults. METHODS: The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from the clinical trial database clinicaltrials.gov, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into six levels of evidence (A-F). As these guidelines are intended for clinical use, the scientific evidence was finally assigned different grades of recommendation to ensure practicability. RESULTS: We identified 10 pharmacological monotherapies or combination treatments with at least limited positive evidence for efficacy in bipolar depression, several of them still experimental and backed up only by a single study. Only one medication was considered to be sufficiently studied to merit full positive evidence. CONCLUSIONS: Although major advances have been made since the first edition of this guideline in 2002, there are many areas which still need more intense research to optimize treatment. The majority of treatment recommendations is still based on limited data and leaves considerable areas of uncertainty.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M., Freemantle, N., Boynton, J., Churchill, R., Eccles, M., Geddes, Jr., Hardy, R., Lewis, G., & Mason, J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 86 · cited 1×
“It has to be added, however, that a Cochrane library metaanalysis established only a tendency, but no signifi cant advantage for SSRI compared to TCA when looking at dropout rates in clinical trials in unipolar patients (Barbui et al. 2000).”
ResultRetractedAn inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 3×
“Other, less frequently used scales in bipolar depression trials include the Inventory of Depressive Symptoms (IDS, (Rush et al. 1986), the self-rated Beck Depression Inventory (BDI; Beck et al. 1961) and the Bech– Rafaelsen Melancholia Scale (MES) (Bech 2002).”
MethodA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 2×
“In addition, unequal quality of studies may substantially impact on CE and derived RG and even appear contradictory to clinical experience (see paragraph on valproate). recent trials choose the Montgomery–Asberg Depression rating scale (MADRS; Montgomery and Asberg 1979).”
BackgroundMethodDevelopment of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410 · cited 9×
“In addition, unequal quality of studies may substantially impact on CE and derived RG and even appear contradictory to clinical experience (see paragraph on valproate). recent trials choose the Montgomery–Asberg Depression rating scale (MADRS; Montgomery and Asberg 1979).”
MethodInfluentialEffectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · cited 2×
“Clinical effectiveness is composed of effi - cacy, safety/tolerability and treatment adherence and persistence (Lieberman et al. 2005).”
Background(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442 · cited 1×
“The issue of severity is important in establishing or clarifying the size of the effect of antidepressants (Kirsch et al. 2008, see also McAllister-Williams 2008; Möller 2008).”
BackgroundPharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“Another methodological limitation is sponsor bias (Lexchin et al. 2003; Perlis et al. 2005; Heres et al. 2006; Lexchin and Light 2006) inherent in many single studies on which the guidelines are based.”
BackgroundThe Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106 · cited 1×
“Although mania is considered as the hallmark of bipolar disorder, major depressive episodes and depressive symptoms place an even more signifi cant burden onto bipolar patients (Judd et al. 2002; Goodwin and Jamison 2007).”
BackgroundCipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654 · cited 1×
“But interestingly, paroxetine and bupropion appear in a recent metaanalysis of 12 newer antidepressants in unipolar depression (Cipriani et al. 2009) to belong to the group of between antidepressant use and switch events, and the evidence from observational studies and retrospective self-reports is…”
Background
Research works printed but not linked: 31
- American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th revised. Washington DC: American Psychiatric Press.
- Anderson J, 2000, J Rheumatol, 27, 540
- Baldessarini RJ, 2003, J Clin Psychiatry, 64, 44
- Ballenger JC, 1988, J Clin Psychiatry, 49, 13
- Barbey JT, 1998, J Clin Psychiatry, 59, 42
- Barbui C, 2000, Cochrane Database Syst RevCD002791
- Dunner DL, 1992, J Clin Psychiatry, 53, 21
- FDA Public Health Advisory, 2004, Electronic Citation US Food and Drug Administration
- Ghaemi SN, 2006, Psychiatr Serv, 57, 660, 10.1176/ps.2006.57.5.660 · DOI · Paper page
- Ghaemi NS, 2008, Medscape J Med, 10, 211
- Grunze HC, 2008, CNS Spectr, 13, 790, 10.1017/S1092852900013912 · DOI · Paper page
- Hurley SC, 2002, Ann Pharmacother, 36, 860, 10.1345/aph.1A102 · doi:10.1345/aph.1a102 · Paper page
- Jon DI, 2008, World J Biol Psychiatry, 10, 1
- Lader MH, 1996, J Clin Psychiatry, 57, 39
- Matkowski K, 1992, Psychiatr Pol, 26, 251
- McElroy SL, 2008, Bipolar Disord, 10, 59
- Miklowitz DJ, 2007, Psychopharmacol Bull, 40, 116
- Miklowitz DJ, 1996, Psychopharmacol Bull, 32, 613
- Muzina DJ, Presented at the 48th Annual New Clinical Drug Evaluation Unit Meeting (NCDEU), May 2008, Phoenix, AZ. 2008
- National Collaborating Centre for Mental Health, 2006, CG38: NICE Guideline. Electronic Citation National Institute for Health and Clinical Excellence
- Rihmer Z, 2005, Clin Neuropsychiatry, 2, 48
- Sachs G, 2002, APA 2002 Syllabus & Proceedings Summary
- Sachs G, 2009, ISCTM 5th Annual Meeting, Arlington VA 3–5 March
- Sachs GS, 1994, J Clin Psychiatry, 55, 391
- Sartorius N, 2007, Int J Neuropsychopharmacol, 10, 1
- Small JG, 1990, Psychopharmacol Bull, 26, 25
- Suppes T, 2008, Presented at the Eighth International Review of Bipolar Disorder Conference, Copenhagen, Denmark, 14
- Valenti M, 2007, Actas Esp Psiquiatr, 35, 199
- World Health Organization, 1992, Clinical Descriptions and Diagnostic Guidelines
- Xia G, 2008, Int J Neuropsychopharmacol, 11, 119
- Young AH, 2008, Bipolar Disord, 10, 451
Cited by
Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770
Self-citationCipriani, A., Barbui, C., Salanti, G., Rendell, J., Brown, R., Stockton, S., Purgato, M., Spineli, L. M., Goodwin, G. M., & Geddes, J. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60873-8 · Cited by 631
Self-citationBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“The guidelines do not address depressive disorders occurring in bipolar affective disorders (see separate WFSBP guideline, Grunze et al. 2010).”
BackgroundSelf-citationMobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality
Nicholas, J., Larsen, M. E., Proudfoot, J., & Christensen, H. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4581 · Cited by 438
““monotherapy with some antidepressants, especially tricyclics, without an accompanying mood stabilizer, however, may be associated with an increased rate of treatment emergent affective switches (TEAS)” Grunze et al, 2010, pp 92 [17] “Lithium, divalproex, olanzapine, and quetiapine, as well as lamotrigine (primarily f…”
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
“As distinct from the guidelines on the treatment of acute episodes (Grunze et al 2009a;Grunze et al 2010), where we dealt with largely similar study designs, the heterogeneity of long term study design leaves greater uncertainty when comparing different treatments.”
BackgroundMethodSelf-citation
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Warneford Hospital (GB)
- The University of Texas at San Antonio Health Science Center (US)
- Aarhus University Hospital (DK)
- Medical University of Vienna (AT)
- Corresponding author
- Grunze, Heinz
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2010-01
- Volume
- 11
- Issue
- 2
- Pages
- 81-109
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2125390848
- Semantic Scholar
- 23f0f14e8b354fcfd4e237fcffb6a54dfebe8008
- Cited by
- 399
- References
- 244
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 8 · 2023: 12 · 2022: 9 · 2021: 22 · 2020: 18 · 2019: 19 · 2018: 21 · 2017: 25 · 2016: 21 · 2015: 34 · 2014: 28 · 2013: 46 · 2012: 45
- FWCI
- 35.77
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Universidad Peruana Cayetano Heredia Institutional Repository (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- bipolar depression, acute bipolar depression, biological treatment, combination therapy, antidepressants, mood stabilizers, treatment efficacy, level of evidence, clinical guidelines
- MeSH terms
- Quetiapine Fumarate, Olanzapine, Lamotrigine, Adolescent, Adult, Antidepressive Agents, Benzodiazepines, Bipolar Disorder, Carbamazepine, Child, Dibenzothiazepines, Electroconvulsive Therapy, Humans, Psychiatric Status Rating Scales, Psychotherapy, Antipsychotic Agents, Triazines, Valproic Acid, Lithium Compounds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. https://app.cochat.ai/papers/10.3109/15622970903555881
- The paper
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders. (2010). The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622970903555881
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.